UHHS Westlake Medical Center

Summary

UHHS Westlake Medical Center is a medical facility located in Westlake, Ohio. This center is recognized for care of Lung Cancer, Breast Cancer, Breast cancer, Prostate Cancer, Ovarian Cancer and other specialties. UHHS Westlake Medical Center is involved with conducting 126 clinical trials across 198 conditions. There are 25 research doctors associated with this hospital, such as Amy Armstrong, MD, Afshin Dowlati, MD, Lauren Henke, MD, and Richard T. Lee.

Top PIs

Clinical Trials running at UHHS Westlake Medical Center

Oropharyngeal Carcinoma

Esophageal Carcinoma

Small Cell Lung Cancer

Throat Cancer

Laryngeal Cancer

Gastroesophageal Junction Adenocarcinoma

Esophageal cancer

Breast Cancer

Brain Tumor

Oral Squamous Cell Carcinoma

Chemotherapy + Radiation Therapy

for Head and Neck Cancer

This phase II/III trial studies how well radiation therapy works when given together with cisplatin, docetaxel, cetuximab, and/or atezolizumab after surgery in treating patients with high-risk stage III-IV head and neck cancer the begins in the thin, flat cells (squamous cell). Specialized radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue. Drugs used in chemotherapy, such as cisplatin and docetaxel, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Cetuximab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. The purpose of this study is to compare the usual treatment (radiation therapy with cisplatin chemotherapy) to using radiation therapy with docetaxel and cetuximab chemotherapy, and using the usual treatment plus an immunotherapy drug, atezolizumab.

Recruiting

1 award

Phase 2 & 3

21 criteria

Radiation Therapy + Cisplatin

for Head and Neck Cancer

This trial is studying if using a specific type of energy treatment alone or with a drug is better for treating patients with advanced head and neck cancer after surgery. The energy treatment kills cancer cells, and the drug helps by stopping their growth or killing them. The drug has been used for many years in the treatment of advanced cancers, including head and neck cancers, and is known for its ability to enhance the effects of the energy treatment.

Recruiting

1 award

Phase 2

19 criteria